Chemical Exposures and Health Care Costs
A new economic analysis has concluded that exposure to endocrine-disrupting chemicals likely costs the European Union €157 billion ($209 billion U.S.) a year in actual health care expenses and lost earning potential, according to a new series of studies published in the Endocrine Society’s Journal of Clinical Endocrinology and Metabolism. A total of four papers were published (overview, neurobehavioral, male reproduction and obesity & diabetes) that focused on specific health conditions that can partly be attributed to endocrine-disrupting chemical (EDC) exposure. These included infertility and male reproductive dysfunction, birth defects, obesity, diabetes,